Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled trial of Huangjia Ruangan Granules for chronic hepatitis B-related liver fibrosis
ChiCTR2400086796Phase 2Completed
- Sponsor
- Shuguang Hospital
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Huangjia Ruangan Granules in Chronic Hepatitis B (CHB) and hepatic fibrosis (3 arms), sponsored by Shuguang Hospital. Primary endpoints: Liver histological changes, FibroScan examination and 5 more. Started Jul 2024; status: completed.
02
Drugs
Huangjia Ruangan Granules
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR2400086796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086796.